HFA
LFCR icon

Harbert Fund Advisors’s Lifecore Biomedical LFCR Stock Holding History

Harbert Fund Advisors’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-152,505
Closed -$1.62M – 37
2021
Q1 		$1.62M Sell
152,505
-146,611
-49% -$1.65M 0.76% 20
2020
Q4 		$3.25M Hold
299,116
– – 2.46% 15
2020
Q3 		$2.91M Sell
299,116
-10,496
-3% -$100K 3.55% 12
2020
Q2 		$2.46M Sell
309,612
-77,223
-20% -$797K 2.81% 14
2020
Q1 		$3.36M Buy
386,835
+18,563
+5% +$193K 5.62% 6
2019
Q4 		$4.17M Buy
368,272
+118,393
+47% +$1.26M 5.57% 6
2019
Q3 		$2.72M Buy
+249,879
New +$2.72M 4.04% 9

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Harbert Fund Advisors's LFCR Position: Q2 2021 in Review

Harbert Fund Advisors sold out of Lifecore Biomedical (LFCR) in Q2 2021, closing a stake of 152,505 shares — an estimated $1.62M sold.

Harbert Fund Advisors first reported a position in LFCR in Q3 2019 and held it in 7 quarters. The position peaked at $4.17M in Q4 2019. 95 funds tracked by Wall St. Rank hold LFCR as of Q2 2021.

  • Harbert Fund Advisors reported no remaining Lifecore Biomedical position as of Q2 2021 after selling out during the quarter.
  • Harbert Fund Advisors sold 152,505 Lifecore Biomedical shares in Q2 2021, an estimated $1.62M.
  • Harbert Fund Advisors first reported a position in Lifecore Biomedical in Q3 2019 and held it in 7 quarters.
  • Harbert Fund Advisors's Lifecore Biomedical position peaked at $4.17M in Q4 2019.
  • 95 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2021.

Based on Harbert Fund Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.